Regeneron has announced that the European Commission ... Gynaecological Oncological Trial groups (ENGOT), and NRG Oncology-Japan. Patients were of a median age of 51 years old – 78% with ...
The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...
Feb 24 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between 10 months and 16 years old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback